Your session is about to expire
← Back to Search
Stem Cell Therapy
Descartes-30 for ARDS Related to COVID-19
Phase 1 & 2
Recruiting
Research Sponsored by Cartesian Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients must be 18 years of age or older at the time of enrollment
Patient maintains a diagnosis of moderate or severe ARDS according to the Berlin definition of ARDS
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trialtests the safety of a new treatment for COVID-19 in people with ARDS.
Who is the study for?
This trial is for adults over 18 with moderate or severe ARDS as defined by the Berlin criteria, who also have COVID-19. It's not open to those in other experimental trials or patients expected to live less than 24 hours.Check my eligibility
What is being tested?
The study is testing the safety of a cell therapy called Descartes-30 in patients suffering from acute respiratory distress syndrome (ARDS) exacerbated by COVID-19 infection.See study design
What are the potential side effects?
Since this is an emergency study for a new treatment, specific side effects of Descartes-30 are being investigated and may include typical reactions related to cellular therapies.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
My condition is diagnosed as moderate or severe ARDS.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To assess the safety of Descartes-30 in patients with moderate-to-severe ARDS.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Descartes 30Experimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Cartesian TherapeuticsLead Sponsor
8 Previous Clinical Trials
218 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.My condition is diagnosed as moderate or severe ARDS.The patient is very sick and not expected to live for more than one day.
Research Study Groups:
This trial has the following groups:- Group 1: Descartes 30
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Coronavirus Patient Testimony for trial: Trial Name: NCT04524962 — Phase 1 & 2
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
California
What site did they apply to?
University of California-Irvine
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1
Why did patients apply to this trial?
This is now the second time I have contracted Covid in the last two years.
PatientReceived no prior treatments
Recent research and studies
Share this study with friends
Copy Link
Messenger